Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue sup1
Open access
642
Views
0
CrossRef citations to date
0
Altmetric
Immunology
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates
Gihan Hamdy Elsisia HTA Office, LLC, Cairo, Egypt;b American University, Cairo, EgyptCorrespondence[email protected]
View further author information
, View further author information
Ahmed Abo Gamalc Gargash Hospital, Dubai, Emirates;d Al Azhar University, Cairo EgyptView further author information
, Waleed AlShehhie Clemenceau Medical Center (CMC), HMS Mirdif Hospital, Dubai, EmiratesView further author information
& Mohamed Farghalyf Dubai Health Authority, Dubai, EmiratesView further author information
Pages 23-34
|
Received 12 Jan 2024, Accepted 15 Feb 2024, Published online: 11 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.